• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 21 of 100
The ADHD drug shortage is spreading as supplies of a popular alternative to Adderall run worryingly low
Health
The ADHD drug shortage is spreading as supplies of a popular alternative to Adderall run worryingly low
By Ike Swetlitz and BloombergJune 20, 2023
Paul Hudson
Success
Gen Z needs brand-new skills to climb to the C-suite: ‘What got me here will not get them there,’ says health care CEO
By Jane ThierJune 2, 2023
GSK’s CEO says you need thick skin if you’re going to step into the C-suite
Leadership
GSK’s CEO says you need thick skin if you’re going to step into the C-suite
By Fortune EditorsMay 31, 2023
Why the underestimated economic burden of rare diseases could be costing the U.S. trillions of dollars
Commentary
Why the underestimated economic burden of rare diseases could be costing the U.S. trillions of dollars
By Giacomo ChiesiMay 25, 2023
A pharmacist waiting on a customer at a pharmacy counter
Health
A Colorado panel of medical and pharmacy experts will decide whose medicine to make affordable this summer
By Markian Hawryluk and KFF Health NewsMay 22, 2023
Sanofi CEO: ‘Europe’s lead in life sciences R&D is eroding–but co-localized hubs could allow it to keep up’
Commentary
Sanofi CEO: ‘Europe’s lead in life sciences R&D is eroding–but co-localized hubs could allow it to keep up’
By Paul HudsonMay 17, 2023
FDA
Health
First-of-its-kind drug for rare form of Lou Gehrig’s disease gets FDA approval
By Matthew Perrone and The Associated PressApril 25, 2023
Mom and son at pharmacy
Health
There’s a small but very real chance that over-the-counter medication could send you to the emergency room, says team that studies medications
By Macarius Mwinisungee Donneyong, Ximena Oyarzún-González and The ConversationApril 21, 2023
How Horizon Therapeutics sold to Amgen for $27.8 billion without ever licensing a drug of its own
Health
How Horizon Therapeutics sold to Amgen for $27.8 billion without ever licensing a drug of its own
By Arthur Allen and KFF Health NewsApril 13, 2023
A zombie apocalypse isn’t likely–but a fungal outbreak is
Commentary
A zombie apocalypse isn’t likely–but a fungal outbreak is
By David AnguloApril 11, 2023
Saundra Pelletier, CEO of Evofem Biosciences.
Newsletters
U.S. women need better birth control. So why is this contraceptive company ‘on life support?’
By Maria Aspan and Kinsey CrowleyApril 5, 2023
A 79-year-old ‘white collar drug dealer’ who sold opioids to pharmacies is going to serve only 2 years in prison
Health
A 79-year-old ‘white collar drug dealer’ who sold opioids to pharmacies is going to serve only 2 years in prison
By Bob Van Voris and BloombergMarch 8, 2023
photo of an "EpiPen" box
Health
After capping the price of insulin, Colorado sets its sights on EpiPen copays
By Helen Santoro and Kaiser Health NewsFebruary 27, 2023
Mark Cuban has been taking on the drug industry. But which one?
Health
Mark Cuban has been taking on the drug industry. But which one?
By Darius Tahir and Kaiser Health NewsFebruary 17, 2023
FDA Commissioner Robert Califf
Health
The first drug to have even a limited impact on Alzheimer’s just got FDA approval. ‘This drug is not a cure.’
By Matthew Perrone and The Associated PressJanuary 6, 2023
1...
  • 19
  • 20
  • 21
  • 22
  • 23
...100
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Personal Finance
Current price of oil as of July 1, 2026placeholder alt text
By Joseph HostetlerJuly 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.